Gossamer Bio Inc (GOSS)
0.7002
-0.03
(-4.08%)
USD |
NASDAQ |
May 17, 16:00
0.69
-0.01
(-1.46%)
After-Hours: 20:00
Gossamer Bio Total Assets (Quarterly): 259.36M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 259.36M |
December 31, 2023 | 311.92M |
September 30, 2023 | 347.92M |
June 30, 2023 | 181.75M |
March 31, 2023 | 219.91M |
December 31, 2022 | 272.45M |
September 30, 2022 | 323.54M |
June 30, 2022 | 245.84M |
March 31, 2022 | 294.68M |
December 31, 2021 | 343.66M |
September 30, 2021 | 387.04M |
June 30, 2021 | 432.51M |
Date | Value |
---|---|
March 31, 2021 | 482.47M |
December 31, 2020 | 539.43M |
September 30, 2020 | 584.18M |
June 30, 2020 | 625.08M |
March 31, 2020 | 371.48M |
December 31, 2019 | 426.60M |
September 30, 2019 | 469.75M |
June 30, 2019 | 507.17M |
March 31, 2019 | 515.95M |
December 31, 2018 | 239.42M |
September 30, 2018 | 262.18M |
December 31, 2017 | 0.445M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
181.75M
Minimum
Jun 2023
625.08M
Maximum
Jun 2020
381.34M
Average
359.70M
Median
Total Assets (Quarterly) Benchmarks
Amicus Therapeutics Inc | 721.79M |
TG Therapeutics Inc | 373.32M |
Replimune Group Inc | 487.72M |
89bio Inc | 577.32M |
Moderna Inc | 16.73B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 232.64M |
Shareholders Equity (Quarterly) | 26.72M |